From One Event to a Global Platform: The Rise of MedTech World with Dr. Dylan Attard, CEO and Co-founder of MedTech World

What started as a one-year break from surgery became a global medtech movement. In this episode, Dr. Dylan Attard, CEO and Co-founder of MedTech World, shares how his journey from surgical training to entrepreneurship led to the creation of MedTech World, now a global platform hosting events across Europe, Asia, the Middle East, and North America. What began as a single event in Malta has evolved into a multi-region ecosystem connecting startups, investors, and healthcare leaders. He highlights the strategic expansion into Florida, a growing yet underrecognized medtech hub, and emphasizes the importance of creating spaces where companies can raise capital and enter new markets. Dr. Attard also reflects on the personal “why” behind his work, sharing how exposure to cardiac innovations, especially after losing his father, reinforces the mission to accelerate life-saving technologies. Tune in to hear how Dr. Dylan Attard scaled MedTech World across continents, and the personal story driving his mission to accelerate life-saving innovation! Resources: Connect with and follow Dr. Dylan Attard on LinkedIn. Follow MedTech World on LinkedIn and explore their website!

Most pharma launch frameworks don’t fail because they lack structure; they fail because they become rigid checklists that kill strategic thinking. In this episode, Lumanity’s Business Development Director, Jeff Hart, and Launch Excellence Principal, Kirsty Tait, talk about how pharmaceutical companies can scale launch excellence as pipelines grow and complexity increases. Kirsty and Jeff explain that rigid, one-size-fits-all frameworks lead to inefficiency, slow decisions, and misalignment across global and local teams. Instead, organizations need a standardized operating system with built-in flexibility to tailor strategy by asset and market. Ultimately, success depends not just on process, but on strong governance, a single source of truth, and a winning culture that drives execution. If your launch process feels slow, inconsistent, or overly complex, this conversation will help you rethink how to scale without losing speed or impact. Resources: Follow Lumanity on LinkedIn and explore their website! Connect with and follow Kirsty Tait on LinkedIn.  Connect with and follow Jeff Hart on LinkedIn.Take a look at the Launch Excellence Health Check here!  Learn more about this series we're doing with Lumanity here:  https://lumanity.com/commercialization-podcasts/

What if the biggest barrier to better healthcare outcomes is… the blood draw itself? In this episode, Web Golinkin, President at Babson Diagnostics, discusses how his company is reinventing blood testing with a patient-friendly, fingertip-based system. He explains why traditional venipuncture drives anxiety and non-adherence, and how BetterWay improves both experience and outcomes. He also shares how automation and simplified workflows reduce operational burden and expand access points for care. Finally, he explores why patient experience is becoming the key competitive differentiator in ambulatory healthcare. Tune in to learn how rethinking a decades-old process could unlock better care, better business, and better patient engagement. Resources: Connect with and follow Web Golinkin on LinkedIn, visit his website, or reach out via email! Follow Babson Diagnostics on LinkedIn and explore their website! Learn more about BetterWay here!

Great medtech innovations win because patients actually use them. In this episode, Ken Nelson, Partner and Founder at Nelson Jennings Ventures, shares his journey from cardiac device sales at Boston Scientific to helping commercialize major players in cardiac monitoring, including iRhythm, BioTelemetry, and Bardy Diagnostics. He highlights how innovations such as wearable cardiac patches have transformed patient adoption and reshaped the monitoring market. Ken reflects on Medtech Innovator's impact in accelerating commercialization, partnerships, and investor readiness. He advises early-stage companies to leverage accelerators and industry events like Life Science Intelligence to strengthen their path to market and fundraising success. Tune in to hear how decades of experience in cardiac monitoring and startup scaling translate into practical advice for founders navigating commercialization and growth! Resources: Connect with and follow Ken Nelson on LinkedIn.

Simplifying the complex world of healthcare reimbursement. In this episode, Jason Considine, President of Experian Health, discusses shifting the industry's focus from denial management to denial prevention by leveraging AI at the point of registration. He discusses the implementation of the Patient Access Curator, a tool that automates insurance discovery and validation to reduce human error and administrative costs. He also explains how Experian leverages rich data assets, such as employment data, to help providers navigate new regulatory requirements, such as the OBBA. This episode explores the mission of leveraging advanced technology to eliminate administrative waste, enabling resources to be redeployed into direct patient care. Tune in to start from the start with denial prevention! Resources Connect with and follow Jason Considine on LinkedIn. Follow Experian Health on LinkedIn and explore their website.

AI is advancing rapidly in healthcare, but speed without governance can create serious clinical, legal, and enterprise-level risks. In this episode, Peter Bonis, MD, Chief Medical Officer at Wolters Kluwer Health, explores how his team is developing reliable, evidence-based AI tools to support frontline clinicians without compromising trust or safety. He explains why clinicians are adopting AI faster than health systems can govern it, creating risks like the rise of “shadow AI.” Peter highlights the importance of transparency, human oversight, and trusted source material in ensuring safe clinical decision support. He also discusses how even experts can be influenced by faulty AI output and why governance models must evolve with frontline input to keep pace. Tune in and learn how healthcare leaders can approach AI governance more responsibly while still supporting innovation at the point of care! Resources: Connect with and follow Dr. Peter Bonis on LinkedIn! Follow Walters Kluwer Health on LinkedIn and visit their website!

Most medtech startups fail before market. The ones that succeed? They plan for it from day one. In this episode, Amanda Helgeson, Business Development Manager at Forj Medical, discusses her work at the CDMO, which helps medtech startups navigate the critical transition from development to manufacturing. She notes that standout companies at Medtech Innovator pair meaningful clinical innovation with the passion and persistence needed to reach the market. Forj differentiates itself by integrating design and manufacturing early, helping companies avoid costly downstream issues. Her core message is to take a holistic, long-term approach, aligning product design, regulatory pathways, and reimbursement strategies from the outset while staying flexible to adapt. Tune in to learn how a holistic, future-focused approach can turn promising ideas into scalable medical devices! Resources: Connect with and follow Amanda Helgeson on LinkedIn. Follow Forj Medical on LinkedIn and explore their website!

Healthcare payments are often discussed as a transparency problem, but the deeper issue is structural fragmentation across contracts, claims, remittances, and workflows. In this episode, Ted Ferrin, Senior Vice President of Payments Innovation at Zelis, explains how the acquisition of Rivet is bringing provider-facing payment intelligence into Zelis’s broader infrastructure. He discusses why achieving financial clarity between payers and providers has been so difficult due to fragmented systems and legacy technology. Ted highlights that true transparency goes beyond simply displaying data and requires meaningful, actionable insights. He also shares how tools like Claims Insights and Zap Edge embed intelligence into payment workflows to reduce rework, improve visibility, and create a smoother experience for providers, payers, and patients. Tune in and learn how better payment intelligence could help turn transparency from a buzzword into real operational trust! Resources: Connect with and follow Ted Ferrin on LinkedIn. Follow Zelis on LinkedIn and visit their website!

Healthcare is drowning in documentation and fragmented data, but what if the system worked for clinicians rather than against them? In this episode, Dr. Richa Gupta, Vice President of Care Transformation at Ambience Healthcare, explains how Ambience provides a layer of intelligence on top of electronic medical records to optimize clinician workflow and patient interactions. Ambience’s ambient listening system captures physician-patient interactions, supports documentation, and ensures accurate coding and billing, boosting clinician satisfaction and reducing revenue leakage. ROI is driven by high clinician utilization, validated outcomes, and measurable improvements in documentation burden, coding accuracy, and physician retention. In 2026, Ambience is expanding across the full care continuum, including ambulatory, emergency, and inpatient settings, offering a platform that surfaces real-time insights and enhances patient care. Tune in to hear how Ambience is transforming physician workflows and delivering real ROI across the care continuum! Resources: Connect with and follow Dr. Richa Gupta on LinkedIn. Follow Ambience Healthcare on LinkedIn and visit their website!

Transformational medtech innovation needs more than a great idea. It needs the right engineering, clinical evidence, reimbursement strategy, and commercialization support to reach patients. In this episode, Peter Lewis, Executive Vice President of Business Development at Hydrix, joins Saul Marquez at the MedTech Innovator Radar Forum to discuss what it takes to bring complex, safety-critical medical devices to market. Peter shares Hydrix’s evolution from its origins in Australia to becoming a global medical product development company supporting cardiac, surgical robotics, imaging, neurostimulation, and other advanced technologies. He highlights why clinician-led innovation is especially powerful, what distinguishes today’s most promising medtech startups, and why AI, reimbursement, and human clinical evidence are now essential pillars for growth. Tune in to learn what medtech innovators need to consider early if they want to build solutions that truly change care. Resources: Connect with and follow Peter Lewis on LinkedIn or reach out via email. Explore the Hydrix website here!